SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-22-011599
Filing Date
2022-04-29
Accepted
2022-04-29 16:45:18
Documents
4
Period of Report
2022-04-29

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 464903
2 formdef14a_001.jpg GRAPHIC 7560
3 proxy_001.jpg GRAPHIC 234147
4 proxy_002.jpg GRAPHIC 229141
  Complete submission text file 0001493152-22-011599.txt   1114542
Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40544 | Film No.: 22876567
SIC: 2834 Pharmaceutical Preparations